Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells.
Takigawa N, Takeyama M, Kozuki T, Shibayama T, Hisamoto A, Kiura K, Tada A, Hotta K, Umemura S, Ohashi K, Fujiwara Y, Takata S, Ichihara E, Osawa M, Tabata M, Tanimoto M, Takahashi K.
Takigawa N, et al. Among authors: ichihara e.
Oncol Rep. 2007 May;17(5):983-7.
Oncol Rep. 2007.
PMID: 17390033